197 related articles for article (PubMed ID: 26008941)
1. Risk tolerance to MS therapies: Survey results from the NARCOMS registry.
Fox RJ; Salter A; Alster JM; Dawson NV; Kattan MW; Miller D; Ramesh S; Tyry T; Wells BW; Cutter G
Mult Scler Relat Disord; 2015 May; 4(3):241-9. PubMed ID: 26008941
[TBL] [Abstract][Full Text] [Related]
2. Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients.
Heesen C; Kleiter I; Meuth SG; Krämer J; Kasper J; Köpke S; Gaissmaier W
J Neurol Sci; 2017 May; 376():181-190. PubMed ID: 28431609
[TBL] [Abstract][Full Text] [Related]
3. A survey of risk tolerance to multiple sclerosis therapies.
Fox RJ; Cosenza C; Cripps L; Ford P; Mercer M; Natarajan S; Salter A; Tyry T; Cofield SS
Neurology; 2019 Apr; 92(14):e1634-e1642. PubMed ID: 30867272
[TBL] [Abstract][Full Text] [Related]
4. Reproductive decision making after the diagnosis of multiple sclerosis (MS).
Alwan S; Yee IM; Dybalski M; Guimond C; Dwosh E; Greenwood TM; Butler R; Sadovnick AD
Mult Scler; 2013 Mar; 19(3):351-8. PubMed ID: 22760102
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey.
Rinker JR; Salter AR; Walker H; Amara A; Meador W; Cutter GR
BMJ Open; 2015 Jan; 5(1):e006714. PubMed ID: 25573524
[TBL] [Abstract][Full Text] [Related]
6. The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Alwan S; Chambers CD; Armenti VT; Sadovnick AD
Mult Scler Relat Disord; 2015 Jan; 4(1):6-17. PubMed ID: 25787048
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis and pregnancy: a comparison study.
Alwan S; Dybalski M; Yee IM; Greenwood TM; Roger E; Nadeau N; Duquette P; Sadovnick AD
Can J Neurol Sci; 2013 Jul; 40(4):590-6. PubMed ID: 23786746
[TBL] [Abstract][Full Text] [Related]
8. High frequency of adverse health behaviors in multiple sclerosis.
Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2009 Jan; 15(1):105-13. PubMed ID: 18845651
[TBL] [Abstract][Full Text] [Related]
9. Patient awareness about family planning represents a major knowledge gap in multiple sclerosis.
Rasmussen PV; Magyari M; Moberg JY; Bøgelund M; Jensen UFA; Madsen KG
Mult Scler Relat Disord; 2018 Aug; 24():129-134. PubMed ID: 30005355
[TBL] [Abstract][Full Text] [Related]
10. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Schairer LC; Foley FW; Zemon V; Tyry T; Campagnolo D; Marrie RA; Gromisch ES; Schairer D
Mult Scler; 2014 Apr; 20(5):610-6. PubMed ID: 23999609
[TBL] [Abstract][Full Text] [Related]
11. "Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry.
Salter AR; Tyry T; Vollmer T; Cutter GR; Marrie RA
Mult Scler; 2013 Jun; 19(7):953-60. PubMed ID: 23257618
[TBL] [Abstract][Full Text] [Related]
12. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis.
Wang G; Marrie RA; Fox RJ; Tyry T; Cofield SS; Cutter GR; Salter A
Mult Scler Relat Disord; 2018 Feb; 20():16-21. PubMed ID: 29275057
[TBL] [Abstract][Full Text] [Related]
13. Causes of death among persons with multiple sclerosis.
Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
[TBL] [Abstract][Full Text] [Related]
14. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
[TBL] [Abstract][Full Text] [Related]
15. Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Oliveira EM; Simm RF; Dasic G; Morais MM; Perreira SL; Callegaro D
Arq Neuropsiquiatr; 2015 Sep; 73(9):736-40. PubMed ID: 26352489
[TBL] [Abstract][Full Text] [Related]
16. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; Saccà F; Baroncini D; Comi G; Trojano M;
Brain; 2015 Nov; 138(Pt 11):3275-86. PubMed ID: 26362907
[TBL] [Abstract][Full Text] [Related]
17. How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis.
Baker D; Anandhakrishnan A; Tuite-Dalton KA; Lockart-Jones H; Middleton RM; Ford DV; Crowe C; Giovannoni G
Mult Scler Relat Disord; 2016 Nov; 10():127-133. PubMed ID: 27919479
[TBL] [Abstract][Full Text] [Related]
18. Validation of the NARCOMS registry: diagnosis.
Marrie RA; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2007 Jul; 13(6):770-5. PubMed ID: 17525097
[TBL] [Abstract][Full Text] [Related]
19. Persistent pain and uncomfortable sensations in persons with multiple sclerosis.
Hadjimichael O; Kerns RD; Rizzo MA; Cutter G; Vollmer T
Pain; 2007 Jan; 127(1-2):35-41. PubMed ID: 16949751
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of young adults with multiple sclerosis: demographic, disease, treatment, and psychosocial characteristics.
Buchanan RJ; Minden SL; Chakravorty BJ; Hatcher W; Tyry T; Vollmer T
Disabil Health J; 2010 Oct; 3(4):262-70. PubMed ID: 21122795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
